Cover Image

The association of cholesterol levels with memory and memory change over a 14‐year period in a US national cohort

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Silvia Miramontes, Umair Khan, Erin L. Ferguson, Marina Sirota, M. Maria Glymour
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Alzheimer's & Dementia: Translational Research & Clinical Interventions
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical factors predicting the rate of cognitive decline in a US memory clinic: An electronic health record study
by: Yuchan Wang, et al.
Published: (2025)

Blood DNA methylation signature of cognitive reserve moderates the association between CSF tau pathology and memory in prodromal Alzheimer's disease
by: David Lukacsovich, et al.
Published: (2026)

Evaluation of amyloid change as a surrogate for cognitive decline: demonstration in individual‐level data from the A4 study of solanezumab
by: Sarah F. Ackley, et al.
Published: (2026)

The plasma p‐tau217/BD‐tau ratio improves biomarker short‐term variability in memory clinic patients
by: Frederikke Kragh Clemmensen, et al.
Published: (2025)

Development and classification accuracy of an automated cognitive screening tool combining working memory and connected speech tasks for early detection of cognitive impairment in primary care
by: Robin C. Hilsabeck, et al.
Published: (2025)

Evaluation of racial and ethnic heterogeneity in the associations of sleep quality and sleep apnea risk with cognitive function and cognitive decline
by: Ruijia Chen, et al.
Published: (2024)

Impact of cognitive training on claims‐based diagnosed dementia over 20 years: evidence from the ACTIVE study
by: Norma B. Coe, et al.
Published: (2026)

Decentralizing dementia research to the US–Mexico border: the Rio Grande Valley AD‐RCMAR as a model for translational equity
by: Gladys E. Maestre, et al.
Published: (2026)

APOE ε4‐independent pathways predominate in the association between retinal nerve fiber layer thinning and 12‐year incident dementia
by: Yuzhuo Wang, et al.
Published: (2025)

Developing, implementing, and evaluating the first national Memory and Cognition Clinic Guidelines in Australia
by: Inga Mehrani, et al.
Published: (2025)

Resources for estimating dementia prevalence at the state and local levels in the United States
by: Erin E. Bennett, et al.
Published: (2026)

Lifestyle medicine and brain health: Insights from the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) and the promise of personalization
by: Alfonso Alfini, et al.
Published: (2025)

Vietnamese Insights into Cognitive Aging Program (VIP): Objectives, study design, and cohort description
by: Oanh L. Meyer, et al.
Published: (2024)

The power of representation: Statistical analysis of diversity in US Alzheimer's disease genetics data
by: Diane Xue, et al.
Published: (2024)

A mindfulness‐based multicomponent caregiver intervention (PAACC): objectives, study design, and cohort description
by: Mamta Sapra, et al.
Published: (2025)

Association of allostatic load with all‐cause and cause‐specific dementia: A prospective cohort study
by: Yifan Gou, et al.
Published: (2025)

Assessing clinical meaningfulness in clinical trials for Alzheimer's disease: A U.S. regulatory perspective
by: Teresa Buracchio, et al.
Published: (2025)

Correction to “Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study”
Published: (2026)

Digital biomarkers: Redefining clinical outcomes and the concept of meaningful change
by: Maria Florencia Iulita, et al.
Published: (2025)

What is older adults’ understanding of Alzheimer's disease research registries? Findings from 20 focus group studies
by: Litty Samuel, et al.
Published: (2025)

Association between plasma p‐tau181 levels and the evolution of cognitive and physical performance in a cohort of cognitively impaired older adults with frailty criteria: Longitudinal data from the CogFrail study
by: Davide Angioni, et al.
Published: (2026)

Low intrinsic capacity is associated with a blunted exercise‐induced cognitive enhancement in physically active middle‐aged and older adults
by: Brandon A. Yates, et al.
Published: (2025)

Combination therapy targeting Alzheimer's disease risk factors is associated with a significant delay in Alzheimer's disease–related cognitive decline
by: Yuan Shang, et al.
Published: (2025)

Genetic associations with psychosis and affective disturbance in Alzheimer's disease
by: Inga Margret Antonsdottir, et al.
Published: (2024)

Meaningful benefit of disease‐modifying treatment: Evaluating changes in health‐related resource use
by: Carolyn W. Zhu, et al.
Published: (2024)

The association of dementia risk symptoms and functional activity in adults with Down syndrome
by: Selena E. Washington, et al.
Published: (2024)

Diabetes mellitus exacerbates changes in white matter hyperintensity shapes and volume: A longitudinal study
by: Shihao Xu, et al.
Published: (2025)

Acute anti‐Aβ antibody exposure induces microglial changes and significantly alters chemokine signaling
by: Kate E. Foley, et al.
Published: (2026)

Safety considerations of semaglutide in the potential treatment of Alzheimer's disease: A pooled analysis of semaglutide in adults aged ≥ 65 years
by: Marwan Sabbagh, et al.
Published: (2025)

Physical activity modifies associations between cerebrospinal fluid tau measures and executive function
by: Ryan J. Dougherty, et al.
Published: (2025)

Activity variability: A novel physical activity metric and its association with cognitive impairment
by: Patrick T. Donahue, et al.
Published: (2025)

Mapping brain change longitudinally: physical activity intervention reshapes structural alterations and functional connectivity in Alzheimer's disease
by: Ravi Dadsena, et al.
Published: (2026)

APOE ‐associated disease risk and sex‐specific effects in Egyptian Alzheimer's disease: an exploratory study
by: Mai Othman, et al.
Published: (2026)

Data‐driven discovery of associations between prescribed drugs and dementia risk: A systematic review
by: Benjamin R. Underwood, et al.
Published: (2025)

Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domains
by: Gregory A. Cary, et al.
Published: (2024)

Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation
by: Reina Tonegawa‐Kuji, et al.
Published: (2025)

Physical activity attenuates the association between allostatic load and early Alzheimer's disease‐related biomarkers in older adults
by: Géraldine Poisnel, et al.
Published: (2026)

Longitudinal associations of apathy and regional tau in mild cognitive impairment and dementia: Findings from the Alzheimer's Disease Neuroimaging Initiative
by: Pranitha Y. Premnath, et al.
Published: (2024)

Cognitive training, alone and combined with acetylcholinesterase inhibitors, in neurocognitive disorders: long‐term efficacy and the role of cognitive reserve on 30 months of intervention
by: Adele Ravelli, et al.
Published: (2026)

Developing educational materials to aid in Alzheimer's blood biomarker disclosure
by: Raymond R. Romano, et al.
Published: (2025)